Bill Sibold Salary and Compensation - MADRIGAL PHARMACEUTICALS, INC. CEO Pay 2024

In fiscal year 2024, Bill Sibold, President and Chief Executive Officer of MADRIGAL PHARMACEUTICALS, INC. (MDGL), received total compensation of $12.2 million.

Bill Sibold's compensation breakdown includes: base salary of $890K, stock awards valued at $7.6 million, option awards of $2.8 million, non-equity incentive compensation of $951K, and other compensation of $10K.

Compared to fiscal year 2023, Bill Sibold's total compensation decreased 62% from $32.3 million to $12.2 million.

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Executive Pay 2024

MADRIGAL PHARMACEUTICALS, INC.'s top 7 named executive officers received combined total compensation of $45.1 million in fiscal year 2024.

The named executive officers disclosed in MADRIGAL PHARMACEUTICALS, INC.'s 2024 proxy statement are:Bill Sibold (President and Chief Executive Officer) with total compensation of $12.2 million, Mardi Dier (Executive Vice President and Chief Financial Officer) with total compensation of $8.8 million, Rebecca Taub (M.D. Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer) with total compensation of $6.0 million, Alex Howarth (Former Senior Vice President and Chief Financial Officer) with total compensation of $5.2 million, Shannon Kelley (Executive Vice President and Chief Legal Counsel) with total compensation of $4.7 million, Brian J. Lynch (Former Senior Vice President and General Counsel) with total compensation of $4.3 million, and Carole Huntsman (Executive Vice President and Chief Commercial Officer) with total compensation of $3.9 million.